After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.

The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

Millions of "long COVID" patients coping with debilitating "brain fog" and chronic fatigue, who are looking for answers to ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

FDA Commissioner Marty Makary announced Thursday that the agency will soon provide clear guidelines to vaccine manufacturers ...

WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive ...

The Trump administration is planning to drop recommendations that pregnant women, teenagers and children get Covid-19 ...

As of April 26, about 14% of pregnant women and 13% of children had received the updated COVID vaccine, according to the CDC.